MedTrace Logo

Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy

NCT02267980 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-10-20

No results posted yet for this study

Summary

The investigators evaluate the effects of a subanesthetic dose of ketamine, administered as an adjunct to sevoflurane, on duration of seizure activity, hemodynamic profile and recovery times during electroconvulsive therapy (ECT) in patients with major depression.

Conditions

  • Depressive Disorder

Interventions

DRUG

Sevoflurane

Inhalation anesthetic agent

DRUG

Ketamine

Intravenous anesthetic agent

DRUG

Saline

Isotonic solution for placebo group

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Feray Erdil, MD · MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02267980 on ClinicalTrials.gov